Increased risk of brain metastases in patients with HER2/neu-positive breast carcinoma

被引：37

作者：

Altaha, R ^{[1
]}

Crowell, E ^{[1
]}

Hobbs, G ^{[1
]}

Higa, G ^{[1
]}

Abraham, J ^{[1
]}

机构：

[1] W Virginia Univ, Mary Babb Randolph Canc Ctr, Hematol Oncol Sect, Morgantown, WV 26506 USA

来源：

CANCER | 2005年 / 103卷 / 03期

关键词：

D O I：

10.1002/cncr.20813

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Data from previous studies have indicated that overexpression of HER-2/neu appears to be correlated with more aggressive disease, increased metastatic potential, and poorer prognosis in patients with breast carcinoma.

引用

页码：442 / 443

页数：2

共 6 条

[1] Meningeal carcinomatosis from breast carcinoma responsive to trastuzumab [J].

Baculi, RH ;

Suki, S ;

Nisbett, J ;

Leeds, N ;

Groves, M .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (13) :3297-3298

[2] Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma [J].

Bendell, JC ;

Domchek, SM ;

Burstein, HJ ;

Harris, L ;

Younger, J ;

Kuter, I ;

Bunnell, C ;

Rue, M ;

Gelman, R ;

Winer, E .

CANCER, 2003, 97 (12) :2972-2977

[3] ASSOCIATION OF C-ERBB-2 PROTEIN OVER-EXPRESSION WITH HIGH-RATE OF CELL-PROLIFERATION, INCREASED RISK OF VISCERAL METASTASIS AND POOR LONG-TERM SURVIVAL IN BREAST-CANCER [J].

KALLIONIEMI, OP ;

HOLLI, K ;

VISAKORPI, T ;

KOIVULA, T ;

HELIN, HH ;

ISOLA, JJ .

INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (05) :650-655

[4]

Lower Elyse E, 2003, Clin Breast Cancer, V4, P114, DOI 10.3816/CBC.2003.n.016

[5] Trastuzumab in CSF [J].

Pestalozzi, BC ;

Brignoli, S .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (11) :2350-2351

[6] Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment [J].

Shmueli, E ;

Wigler, N ;

Inbar, M .

EUROPEAN JOURNAL OF CANCER, 2004, 40 (03) :379-382

← 1 →